Acorn-Capital-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "TRVI",
  "BCAX",
  "TERN",
  "ACRV",
  "BCAB",
  "OKUR",
  "PBYI",
  "QTTB",
  "WHWK",
  "CYBN",
  "TARA",
  "AURA",
  "URGN",
  "VSTM",
  "VYNE",
  "XFOR",
  "YMAB",
  "OPTN",
  "MURA",
  "CADL",
  "CRDF",
  "CGON"
]

Filing Details

13F-HR/A • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-19
Total Holdings: 22
Total Value: 149945296
Accession Number: 0001636587-25-000021
Form Type: 13F-HR/A
CIK: acorn-capital-advisors
Manager Name: Acorn-Capital-Advisors

Data Enrichment

100% identified

22 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

22 positions • $149.9M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

VYNE Therapeutics Inc.

VYNE|92941V308

Shares:785.9K

Value:$1.2M

% of Portfolio:0.8% ($1.2M/$149.9M)

Acrivon Therapeutics, Inc.

ACRV|004890109

Shares:405.2K

Value:$822.6K

% of Portfolio:0.5% ($822.6K/$149.9M)

Instrument	Shares		Other Manager	Value	% of Portfolio
VYNE Therapeutics Inc.(VYNEcusip92941V308)	785.9K	QoQ +71.98% (-329.0K) YoY-	All Managers (Combined)	$1.2M	0.8% ($1.2M/$149.9M)	QoQ -18.88% (-$289.1K) YoY-
Acrivon Therapeutics, Inc.(ACRVcusip004890109)	405.2K	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$822.6K	0.5% ($822.6K/$149.9M)	QoQ -66.27% (-$1.6M) YoY-